Company registration number 04303031 (England and Wales)
ORTHOMED (UK) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
ORTHOMED (UK) LIMITED
CONTENTS
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 4
ORTHOMED (UK) LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
3
64
64
Current assets
Stocks
1,592,548
1,317,576
Debtors
3,250,521
2,775,920
Cash at bank and in hand
99,801
1,096,824
4,942,870
5,190,320
Creditors: amounts falling due within one year
(309,925)
(872,827)
Net current assets
4,632,945
4,317,493
Net assets
4,633,009
4,317,557
Capital and reserves
Called up share capital
4
400
400
Capital redemption reserve
60,000
60,000
Profit and loss reserves
4,572,609
4,257,157
Total equity
4,633,009
4,317,557
ORTHOMED (UK) LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with section 444 of the Companies Act 2006, all of the members of the company have consented to the preparation of abridged financial statements pursuant to paragraph 1A of Schedule 1 to the Small Companies and Groups (Accounts and Directors’ Report) Regulations (SI 2008/409)(b).

The director of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 29 July 2026 and are signed on its behalf by:
N Eric
Director
Company registration number 04303031 (England and Wales)
ORTHOMED (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Orthomed (UK) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 5th Floor One New Change, London, EC4M 9AF.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover represents the fair value of the consideration receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates. Turnover is recognised on the provision of service obligations where a right to consideration is due.

1.3
Fixed asset investments

Fixed asset investments are stated at cost less provision for diminution in value.

1.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.6
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.7
Foreign exchange

Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All differences are taken to profit and loss account.

ORTHOMED (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
8
8
3
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
64
64
4
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
300
300
300
300
A Ordinary shares of £1 each
80
80
80
80
B Ordinary shares of £1 each
20
20
20
20
400
400
400
400
5
Parent company

The parent company is Squared MT Holdings Ltd, a company incorporated in England and Wales, whose registered office is 5th Floor One New Change, London, EC4M 9AF.

 

2025-12-312025-01-01falsefalsefalse29 July 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityJ B FinegoldDr S DhupaG SnodgrassN EricGravitas Company Secretarial Services Limited043030312025-01-012025-12-31043030312025-12-31043030312024-12-3104303031core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3104303031core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3104303031core:ShareCapital2025-12-3104303031core:ShareCapital2024-12-3104303031core:CapitalRedemptionReserve2025-12-3104303031core:CapitalRedemptionReserve2024-12-3104303031core:RetainedEarningsAccumulatedLosses2025-12-3104303031core:RetainedEarningsAccumulatedLosses2024-12-3104303031core:ShareCapitalOrdinaryShareClass12025-12-3104303031core:ShareCapitalOrdinaryShareClass12024-12-3104303031core:ShareCapitalOrdinaryShareClass22025-12-3104303031core:ShareCapitalOrdinaryShareClass22024-12-3104303031core:ShareCapitalOrdinaryShareClass32025-12-3104303031core:ShareCapitalOrdinaryShareClass32024-12-3104303031core:ShareCapitalOrdinaryShares2025-12-3104303031core:ShareCapitalOrdinaryShares2024-12-3104303031bus:Director42025-01-012025-12-31043030312024-01-012024-12-3104303031bus:OrdinaryShareClass12025-01-012025-12-3104303031bus:OrdinaryShareClass22025-01-012025-12-3104303031bus:OrdinaryShareClass32025-01-012025-12-3104303031bus:OrdinaryShareClass12025-12-3104303031bus:OrdinaryShareClass12024-12-3104303031bus:OrdinaryShareClass22025-12-3104303031bus:OrdinaryShareClass22024-12-3104303031bus:OrdinaryShareClass32025-12-3104303031bus:OrdinaryShareClass32024-12-3104303031bus:AllOrdinaryShares2025-12-3104303031bus:AllOrdinaryShares2024-12-3104303031bus:PrivateLimitedCompanyLtd2025-01-012025-12-3104303031bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3104303031bus:FRS1022025-01-012025-12-3104303031bus:AuditExemptWithAccountantsReport2025-01-012025-12-3104303031bus:Director12025-01-012025-12-3104303031bus:Director22025-01-012025-12-3104303031bus:Director32025-01-012025-12-3104303031bus:CompanySecretary12025-01-012025-12-3104303031bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP